English | Nederlands

New Wellnomics White Paper

Jan 28, 2016

What's wrong with sitting?

A research review of the risks associated with sedentary (sitting) behavior.

In the wake of mass media dubbing sitting as ‘the new smoking’ Wellnomics have commissioned an extensive review of the research literature on the risks of sedentary work to help their customers sift fact from fiction.  With a particular focus on office workers the paper review the published evidence behind the many risks being claimed for sitting, and covers the following areas:

  • The health risks of sitting
  • Sitting and musculoskeletal pain
  • Sitting, metabolic syndrome and type 2 diabetes
  • Sitting and cardiovascular disease
  • Sitting and cancer
  • Sitting and mortality
  • Why does sitting cause health risks?

   View white paper   

About Wellnomics

Founded in 1997 by directors Dr Kevin Taylor and Dr Rob van Nobelen, Wellnomics® is a leader in the office ergonomics software field, with many thousands of clients across North America, Australasia and Europe and over 1 million software product licenses in use worldwide. Clients include Global 1000 organisations such as Philips, Boeing (NASA), Chevron, Intel, Shell, BP, ING Bank, KPMG, PWC, US Department of Energy, Cap Gemini, Nike, and Eli Lilly.

Wellnomics provides an integrated suite of software that helps organisations effectively manage the health and safety of large numbers of office workers. Wellnomics products are designed to meet legislative requirements, improve productivity and prevent injuries, and are underpinned by extensive international research.

At any one time Wellnomics is involved with numerous scientific studies on computer use in the office environment around the world. These activities allow Wellnomics to ensure its products are scientifically validated and provide objectively measurable improvements to health and safety outcomes. For more information, see wellnomics.com/research/white-papers.